Aktan Abdykalykov

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab for Early Triple-Negative Breast Cancer

   · 2020 · cited 2,766x

2. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

   · 2020 · cited 1,522x

3. Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

   · 2016 · cited 1,263x

4. iNOS-mediated nitric oxide production and its regulation

   · 2004 · cited 1,126x

5. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

   · 2012 · cited 1,113x

via Crossref · CC0

Wikidata facts

Image